Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Connecticut Children's Medical Center
This is a prospective, randomized, controlled study of children with persistent asthma who are managed on daily inhaled corticosteroids (ICS). 75 children will be randomized 2:1 into one of two arms:
* 50 children will be randomized to BreatheSmart, comprised of:
* BreatheSmart mobile application that tracks medication usage and sends real time reminders
* HeroTracker sensor that counts dosage and monitors real-time medication adherence
* CoheroConnect provider portal that allows the Investigator to monitor real-time adherence and to provide targeted outreach to children with low adherence (intervention arm)
* 25 children will be randomized to "standard of care"(control arm). These patients are reminded to adhere to the prescribed standard of care therapy provided by their clinician during their clinical encounters and when the family calls to report an illness.
Age
8–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 8 to 17
Diagnosis of persistent asthma
Prescribed an inhaled corticosteroid (ICS) for at least one month prior to enrollment
Use of a pressurized metered dose inhaler (pMDI) compatible with the Cohero mHealth Herotracker (See Appendix)
Parent/child possess a compatible smartphone (iOS 8.0 or higher)
English or Spanish speaking
You may not be if
Presence of another chronic lung disease or condition such as cystic fibrosis, interstitial lung disease, chronic lung disease of prematurity, recurrent aspiration, or presence of tracheostomy
Presence of other chronic medical condition such as congenital heart disease or immunodeficiency
Presence of other comorbidities that, in the opinion of the investigator, will interfere with collection of study procedures, or limits life expectancy to \< 1 year
Currently pregnant or planning to become pregnant during the trial period